ACUTE DECOMPENSATED HEART FAILURE
Clinical trials for ACUTE DECOMPENSATED HEART FAILURE explained in plain language.
Never miss a new study
Get alerted when new ACUTE DECOMPENSATED HEART FAILURE trials appear
Sign up with your email to follow new studies for ACUTE DECOMPENSATED HEART FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New catheter offers hope for heart failure patients resistant to diuretics
Disease control OngoingThis study tests a new device called the Doraya Catheter in 30 adults hospitalized with acute heart failure who have fluid buildup that doesn't respond well to standard water pills (diuretics). The catheter is designed to help remove excess fluid from the body. The goal is to see…
Matched conditions: ACUTE DECOMPENSATED HEART FAILURE
Phase: NA • Sponsor: Revamp Medical Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New heart pump could buy time for failing hearts
Disease control OngoingThis study tests a temporary heart pump called Impella BTR in 10 adults with severe heart failure. The pump is placed inside the body to help the heart pump blood for up to 28 days. The goal is to see if it is safe and can support patients until their heart recovers or they recei…
Matched conditions: ACUTE DECOMPENSATED HEART FAILURE
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Heart failure AI trial pulled before it began
Disease control TerminatedThis study aimed to see if an AI program could help doctors choose better medications for people with chronic heart failure. It planned to compare standard care to AI-generated treatment plans. However, the study was withdrawn before any participants were enrolled, so no results …
Matched conditions: ACUTE DECOMPENSATED HEART FAILURE
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New drug shows promise for hospitalized heart failure patients
Symptom relief OngoingThis early-stage trial tests a drug called atibuclimab (IC14) in 10 adults hospitalized with acute decompensated heart failure. The main goals are to check if the drug is safe and how it affects heart failure markers. Participants receive one IV dose and are followed for 3 months…
Matched conditions: ACUTE DECOMPENSATED HEART FAILURE
Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Symptom relief
Last updated May 17, 2026 05:07 UTC